205 related articles for article (PubMed ID: 16520133)
21. [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha].
D'Angelo-Mendoza E; Rodríguez-Bonfante C; Camacho I; Martínez J; Perdomo T; Cabrera A; Bonfante-Cabarcas R
Invest Clin; 2005 Sep; 46(3):229-40. PubMed ID: 16152779
[TBL] [Abstract][Full Text] [Related]
22. Left ventricular circulatory support as bridge to heart transplantation in Chagas' disease cardiomyopathy.
Moreira LF; Galantier J; Benício A; Leirner AA; Cestari IA; Stolf NA
Artif Organs; 2007 Apr; 31(4):253-8. PubMed ID: 17437492
[TBL] [Abstract][Full Text] [Related]
23. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
[TBL] [Abstract][Full Text] [Related]
24. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
25. Reactivation of cardiac Chagas' disease in acquired immune deficiency syndrome.
Rivera J; Hillis LD; Levine BD
Am J Cardiol; 2004 Oct; 94(8):1102-3. PubMed ID: 15476640
[TBL] [Abstract][Full Text] [Related]
26. [Chronic Chagas' cardiopathy-- use of vasodilators in uncompensated heart failure].
Marin-Neto JA; Secches AL; Maciel BC; Gallo Júnior L; Terra-Filho J; Manço JC; Amorin DS
Arq Bras Cardiol; 1982 Apr; 38(4):291-9. PubMed ID: 7168662
[No Abstract] [Full Text] [Related]
27. [Chagas' disease and ischemic stroke].
Carod-Artal FJ
Neurologia; 2006 Apr; 21(3):135-49. PubMed ID: 16575627
[TBL] [Abstract][Full Text] [Related]
28. A risk score for predicting death in Chagas' heart disease.
Kamath SA; Drazner MH
N Engl J Med; 2006 Dec; 355(23):2489; author reply 2490-1. PubMed ID: 17162762
[No Abstract] [Full Text] [Related]
29. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
30. Distinctive impaired cardiac autonomic modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases.
Vasconcelos DF; Junqueira LF
J Electrocardiol; 2009; 42(3):281-9. PubMed ID: 19095247
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of low output syndrome in chronic Chagas cardiopathy].
López M; da Silva OA; Amaral CF; Lopes JA; da Silveira JC; Fonseca JG; de Oliveira JS; Cardini JF
Arq Bras Cardiol; 1980 Mar; 34(3):185-9. PubMed ID: 7436775
[No Abstract] [Full Text] [Related]
32. Impact of a comprehensive telephone-based disease management programme on quality-of-life in patients with heart failure.
Ramachandran K; Husain N; Maikhuri R; Seth S; Vij A; Kumar M; Srivastava N; Prabhakaran D; Airan B; Reddy KS
Natl Med J India; 2007; 20(2):67-73. PubMed ID: 17802984
[TBL] [Abstract][Full Text] [Related]
33. [Thromboembolism in patients with apical lesion caused by chronic chagasic cardiopathy].
Albanesi Filho FM; Gomes Filho JB
Rev Port Cardiol; 1991 Jan; 10(1):35-42. PubMed ID: 2059463
[TBL] [Abstract][Full Text] [Related]
34. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.
Gottlieb SS; Kop WJ; Thomas SA; Katzen S; Vesely MR; Greenberg N; Marshall J; Cines M; Minshall S
Am Heart J; 2007 May; 153(5):868-73. PubMed ID: 17452166
[TBL] [Abstract][Full Text] [Related]
35. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device.
Klodell CT; Aranda JM; McGiffin DC; Rayburn BK; Sun B; Abraham WT; Pae WE; Boehmer JP; Klein H; Huth C
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):188-95. PubMed ID: 18179940
[TBL] [Abstract][Full Text] [Related]
36. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
37. [Effects of amiodarone on the elastic properties of the left ventricle in chronic Chagas' cardiomyopathy].
Bellotti G; de Moraes AV; Silva LA; Galiano N; Rati M; Esteves Filho A; Ramires JA; Pileggi F
Arq Bras Cardiol; 1983 Jul; 41(1):71-5. PubMed ID: 6667162
[No Abstract] [Full Text] [Related]
38. Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy?
Silva CP; Del Carlo CH; Oliveira Junior MT; Scipioni A; Strunz-Cassaro C; Ramirez JA; Pereira Barretto AC
Arq Bras Cardiol; 2008 Dec; 91(6):358-62. PubMed ID: 19142362
[TBL] [Abstract][Full Text] [Related]
39. Improved health-related quality of life and functional status after surgical ventricular restoration.
Sartipy U; Albåge A; Lindblom D
Ann Thorac Surg; 2007 Apr; 83(4):1381-7. PubMed ID: 17383343
[TBL] [Abstract][Full Text] [Related]
40. Effect of dyspnea and clinical variables on the quality of life and functional capacity in patients with chronic obstructive pulmonary disease and congestive heart failure.
Karapolat H; Eyigor S; Atasever A; Zoghi M; Nalbantgil S; Durmaz B
Chin Med J (Engl); 2008 Apr; 121(7):592-6. PubMed ID: 18466677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
